InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（12 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
12
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Explore the full record of transactions filed by Harford Simon N.R., 首席财务官. Insider active across 2 companies, notably Albireo Pharma, INC.. Cumulatively, 23 reports have been recorded. Split: 0 buy · 12 sells. Total volume traded: €108k. History available since 13 July 2021. The latest transaction was filed on 27 April 2026 (Disposition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Harford Simon N.R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报23 总计
143,595 股@ US$14.500.045% mcap62.5% 占其流量Common StockSEC:0001193125-26-182244:0
71,303 股@ US$14.2580.9% 占其流量Common StockSEC:0001193125-25-337337:0
12,529 股@ US$7.602.8% 占其流量Common StockSEC:0001443705-25-000004:0
7,482 股@ US$9.316.3% 占其流量Common StockSEC:0000950170-25-002421:0
12,529 股@ US$12.0912.7% 占其流量Common StockSEC:0000950170-24-100253:0
57,392 股0Common StockSEC:0000950170-24-002094:0
106,973 股0Common StockSEC:0001209191-23-047104:0
13,739 股Common StockSEC:0001209191-23-014786:0
55,000 股0Common StockSEC:0001209191-23-005333:0
55,000 股0Common StockSEC:0001209191-23-004948:0
102 股@ US$43.803.3% 占其流量Common StockSEC:0001209191-23-004453:0
1,776 股@ US$43.8057.5% 占其流量Common StockSEC:0001209191-23-004219:0
104 股@ US$19.57641.6% 占其流量Common StockSEC:0001209191-22-054487:0
80 股@ US$23.78581.6% 占其流量Common StockSEC:0001209191-22-053556:0
106 股@ US$24.67132.0% 占其流量Common StockSEC:0001209191-22-043106:0
95 股@ US$24.02761.8% 占其流量Common StockSEC:0001209191-22-042038:0
103 股@ US$32.92472.9% 占其流量Common StockSEC:0001209191-22-025525:0
96 股@ US$35.74392.9% 占其流量Common StockSEC:0001209191-22-023974:0
416 股@ US$24.88228.4% 占其流量Common StockSEC:0001209191-22-004807:0
21,600 股0Common StockSEC:0001209191-22-004063:0
111 股@ US$25.94642.3% 占其流量Common StockSEC:0001209191-22-002923:0
93 股@ US$30.23392.2% 占其流量Common StockSEC:0001209191-21-060216:0
98 股@ US$35.022.7% 占其流量Common StockSEC:0001209191-21-046787:0
23 条申报中的 23 条
About Harford Simon N.R.
Harford Simon N.R. is Directeur Financier. He is linked to Albireo Pharma, INC. as CFO and Treasurer, and to Amicus Therapeutics, INC. as Chief Financial Officer. His total number of filings is 23. Among the sampled recent filings from 2021-07-15 to 2026-04-27, sales total 1884342 EUR and the modal transaction nature is Cession.
